While antioxidants and other similar therapies aimed at lowering global oxidative stress have shown little efficacy in human trials, we have previously shown the benefits of using a targeted, shielding RhoA peptide in a mouse model of LPS induced ALI [11]. This evidence concerns the gene RHOA and acute respiratory distress syndrome.